Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristofer Wollein Waldetoft

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Microbiology|November 19, 2013
To harm or not to harm? On the evolution and expression of virulence in group A streptococciKristofer Wollein Waldetoft, Lars Råberg
Plos Biology|December 29, 2017
Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challengeKristofer Wollein Waldetoft, Sam P Brown
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2022
Evolving antibiotic spectrumKristofer Wollein Waldetoft, Sam P Brown
Future Microbiology|October 7, 2015
Localization-triggered bacterial pathogenesisRolf Lood, Kristofer Wollein Waldetoft, Pontus Nordenfelt
Evolutionary Applications|May 21, 2020
Proliferation and benevolence-A framework for dissecting the mechanisms of microbial virulence and health promotionKristofer Wollein Waldetoft, Lars Råberg, Rolf Lood
Natural Product Reports|December 16, 2021
Challenges and opportunities for cheat therapy in the control of bacterial infectionsJames Gurney, Camille Simonet, Kristofer Wollein Waldetoft, et al.
Msphere|April 28, 2025
Risk of death during acute infection is accelerating across diverse host-pathogen systems and consistent with multiple models of host-pathogen interactionTim O'Sullivan, Canan Karakoç, Kristofer Wollein Waldetoft, et al.
Mbio|December 8, 2022
Defining the Benefits of Antibiotic Resistance in Commensals and the Scope for Resistance OptimizationKristofer Wollein Waldetoft, Sarah Sundius, Rachel Kuske, et al.
Epidemics|December 1, 2023
Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of diseaseBenjamin J Metcalf, Kristofer Wollein Waldetoft, Bernard W Beall, et al.
Plos Biology|May 17, 2019
Resistance diagnostics as a public health tool to combat antibiotic resistance: A model-based evaluationDavid McAdams, Kristofer Wollein Waldetoft, Christine Tedijanto, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Microbiology|November 19, 2013
To harm or not to harm? On the evolution and expression of virulence in group A streptococciKristofer Wollein Waldetoft, Lars Råberg
Plos Biology|December 29, 2017
Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challengeKristofer Wollein Waldetoft, Sam P Brown
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2022
Evolving antibiotic spectrumKristofer Wollein Waldetoft, Sam P Brown
Future Microbiology|October 7, 2015
Localization-triggered bacterial pathogenesisRolf Lood, Kristofer Wollein Waldetoft, Pontus Nordenfelt
Evolutionary Applications|May 21, 2020
Proliferation and benevolence-A framework for dissecting the mechanisms of microbial virulence and health promotionKristofer Wollein Waldetoft, Lars Råberg, Rolf Lood
Natural Product Reports|December 16, 2021
Challenges and opportunities for cheat therapy in the control of bacterial infectionsJames Gurney, Camille Simonet, Kristofer Wollein Waldetoft, et al.
Msphere|April 28, 2025
Risk of death during acute infection is accelerating across diverse host-pathogen systems and consistent with multiple models of host-pathogen interactionTim O'Sullivan, Canan Karakoç, Kristofer Wollein Waldetoft, et al.
Mbio|December 8, 2022
Defining the Benefits of Antibiotic Resistance in Commensals and the Scope for Resistance OptimizationKristofer Wollein Waldetoft, Sarah Sundius, Rachel Kuske, et al.
Epidemics|December 1, 2023
Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of diseaseBenjamin J Metcalf, Kristofer Wollein Waldetoft, Bernard W Beall, et al.
Plos Biology|May 17, 2019
Resistance diagnostics as a public health tool to combat antibiotic resistance: A model-based evaluationDavid McAdams, Kristofer Wollein Waldetoft, Christine Tedijanto, et al.
Pageof 2